C84.48
Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Peripheral T-cell lymphoma, not elsewhere classified (NOS), with multiple lymph node involvement, is a rare type of blood cancer that originates in T-lymphocytes, a type of white blood cell vital for immune response. This condition falls under the broader category of non-Hodgkin lymphomas and is characterized by the proliferation of malignant T-cells in various lymph node groups throughout the body. Due to its complexity and varied presentation, accurate diagnosis and classification are essential for optimizing treatment strategies.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal T-cell growth Chronic immune system stimulation, possibly due to infections or autoimmune disorders Exposure to certain chemicals or environmental toxins Previous medical treatments such as chemotherapy or radiation, which may alter immune cell behavior In some cases, the cause remains unknown
Key Symptoms: Enlarged lymph nodes that are painless, commonly observed in neck, armpits, or groin Unexplained weight loss Persistent fever or night sweats Fatigue and weakness Unintentional weight loss over a short period Persistent itching or skin rashes Abdominal pain or swelling, if lymph nodes in the abdomen are affected Shortness of breath or cough, if chest lymph nodes are involved
Diagnostic & Treatment
Diagnosis Path: Physical examination to assess lymph node enlargement and other symptoms Imaging studies such as CT scans, PET scans, or MRI to identify the extent and distribution of affected lymph nodes Lymph node biopsy, where a sample tissue is examined microscopically to confirm malignant T-cell presence Immunophenotyping using immunohistochemistry and flow cytometry to determine cell characteristics Molecular testing to identify specific genetic mutations or markers associated with the disease Blood tests to evaluate overall health and detect any related abnormalities
Treatment Protocols: Chemotherapy regimens aimed at destroying cancerous T-cells Targeted therapy utilizing medications designed to interrupt specific pathways involved in T-cell proliferation Radiation therapy to regions with localized lymph node involvement Stem cell transplant, especially in cases where the disease is aggressive or relapses after initial therapy Participation in clinical trials testing new treatments and medical advances Supportive care to manage symptoms and improve quality of life, including medications for pain, infections, or other complications
Clinical Advice & FAQs
Billing Guidance
Is C84.48 a billable ICD-10 code?
Yes, C84.48 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.48?
Clinical documentation must specify the nature of Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference